Allied Market Research

2024

U.s. And Europe Head Lice Infestation Drugs Market

U.S. and Europe Head Lice Infestation Drugs Market Size, Share, Competitive Landscape and Trend Analysis Report by Type : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies

  • Jun 2024

  • Pages: NA

  • Tables: NA

  • Charts: NA

Select an option
Online Only (10% Off) $3,690 $3,321
Data Pack/Excel (10% Off) $3,840 $3,456
Single User License (10% Off) $5,820 $5,238
Five User License (10% Off) $6,540 $5,886
Enterprise User License (10% Off) $9,870 $8,883
Library Membership (15% Off) $1,175 $999
Enquiry Now
Author's: | Roshan Deshmukh
Publish Date:
Enquire Before Buying Customization Request Speak with Analyst

Get Sample to Email

  U.S. and Europe Head Lice Infestation Drugs Market Report Highlights

Aspects Details
icon_5
By Type
  • LOTION
  • CREAMS
  • SHAMPOO
  • OTHERS
icon_6
By Region
  • Europe  (germany, france, uk, italy, spain, rest of europe)
icon_7
Key Market Players

Taro Pharmaceutical, Omega Pharma NV, Prestige Brands Holdings, Inc., Ranbaxy Laboratories, Sanofi-Aventis, Perrigo Plc, Aveka Group, Bayer Healthcare, GlaxoSmithKline Plc, Merck & Co.

Loading Table Of Content...

U.S. and Europe Head Lice Infestation Drugs Market

Global Opportunity Analysis and Industry Forecast, 2023-2032

help@alliedmarketresearch.com